Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.
Injury to a specific neural pathway detected by Ultra-high-field MRI.
Phenytoin in acute optic neuritis: neuroprotective or not?
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.
[Anti-MOG antibody in different types of immune-mediated optic neuritis].
A modified superantigen rescues Ly6G(-)CD11b(+)blood monocyte suppressor function and suppresses antigen-specific inflammation in EAE.
Ciliary Neurotrophic Factor Role in Myelin Oligodendrocyte Glycoprotein Expression in Cuprizone-Induced Multiple Sclerosis Mice.
Association of vitamin D and multiple sclerosis in India.
Diffusion tensor imaging of extraocular muscle using two-dimensional single-shot interleaved multiple inner volume imaging diffusion-weighted EPI at 3 tesla.
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Treadmill training in multiple sclerosis: can body weight support or robot assistance provide added value? A systematic review.
A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.
Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis.
Determinants of ligand binding and catalytic activity in the myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase.
Acute Transverse Myelitis Associated With Human Parvovirus B19 Infection.
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
Initiating oral fingolimod treatment in patients with multiple sclerosis.
Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS.
Chronic pain in episodic illness and its influence on work occupations: A scoping review.
Biomechanical disorders of foot in multiple sclerosis.
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Development of a cell-based assay for the detection of anti-aquaporin 1 antibodies in neuromyelitis optica spectrum disorders.
Leg spasticity and ambulation in multiple sclerosis.
Modulation of Glutamate Transport and Receptor Binding by Glutamate Receptor Antagonists in EAE Rat Brain.
Pages
« first
‹ previous
…
327
328
329
330
331
332
333
334
335
…
next ›
last »